FDA's commitment to transparency

被引：0

作者：

Guharoy, Roy ^{[1
,2
]}

Krenzelok, Edward ^{[3
]}

机构：

[1] Baptist Hlth, Dept Pharm, Montgomery, AL 36117 USA

[2] Univ Massachusetts, Sch Med, Montgomery, AL 36117 USA

[3] Univ Pittsburgh, Sch Pharm, Pittsburgh, PA USA

来源：

AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY | 2021年 / 78卷 / 17期

关键词：

D O I：

10.1093/ajhp/zxab053

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：1550 / 1551

页数：2

共 5 条

[1] Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial) [J].

Agarwal, Anup ;

Mukherjee, Aparna ;

Kumar, Gunjan ;

Chatterjee, Pranab ;

Bhatnagar, Tarun ;

Malhotra, Pankaj .

BMJ-BRITISH MEDICAL JOURNAL, 2020, 371

[2]

[Anonymous], COR DIS 2019 COVID 1

[3] A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia [J].

Simonovich, V. A. ;

Pratx, L. D. Burgos ;

Sabana, P. ;

Beruto, M., V ;

Vallone, M. G. ;

Vazquez, C. ;

Savoy, N. ;

Giunta, D. H. ;

Perez, L. G. ;

Sanchez, M. L. ;

Gamarnik, A., V ;

Ojeda, D. S. ;

Santoro, D. M. ;

Camino, P. J. ;

Antelo, S. ;

Rainero, K. ;

Vidiella, G. P. ;

Miyazaki, E. A. ;

Cornistein, W. ;

Trabadelo, O. A. ;

Ross, F. M. ;

Spotti, M. ;

Funtowicz, G. ;

Scordo, W. E. ;

Losso, M. H. ;

Ferniot, I ;

Pardo, P. E. ;

Rodriguez, E. ;

Rucci, P. ;

Pasquali, J. ;

Fuentes, N. A. ;

Esperatti, M. ;

Speroni, G. A. ;

Nannini, E. C. ;

Matteaccio, A. ;

Michelangelo, H. G. ;

Follmann, D. ;

Lane, H. C. ;

Belloso, W. H. .

NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (07) :619-629

[4]

US FDA, COR COVID 19 UPD FDA

[5]

US Food and Drug Administration, COVID 19 UPD FDAS ON

← 1 →